KEEP is designed to meet the unique challenges faced by patients, helping manage their daily dosing regimens seamlessly integrating into patients’ lives, improving adherence and reducing treatment burdens. In tandem, KEEP supports pharma, unlocking deep insights into the patient and supporter experience.
passively capture dosing events
real time insights for manufacturers and health system partners
Key Challenge:
Lack of real-world experience and actionable insights. Current data is delayed or incomplete.
KEEP’s Solution:
KEEP passive medication tracking provides daily, real-time insights on dosing behavior, the why behind experiences, and measures the impact of interventions.
Key Challenge:
Risk of disruption with initial dose escalation regimen.
KEEP’s Solution:
Personalized treatment plans aligned to the initial 7 day escalation schedule – reminders and notifications to keep patients on track. If 1 dose is missed, we know.
Key Challenge:
Missed doses causing patients to re-enter the initiation phase of treatment.
KEEP’s Solution:
Post initiation phase, tracking the daily dosing regimen of patients – classifying their dosing behavior – and escalation if treatment is interrupted.
While real-world data captures how patients take their medication, KEEP goes beyond that with Real World Experience (RWE-X). RWE-X captures the true, human experience of living with complex conditions, giving pharma companies insights into how patients navigate their day-to-day lives with their treatment. This deeper understanding allows healthcare providers to offer more personalized and timely support, ultimately improving outcomes and patient satisfaction.
Pilot Phase
In the initial pilot phase, KEEP will be deployed to a select group of patients on Zeposia to demonstrate its impact on adherence and patient engagement.
Evaluation & Scaling
Following the pilot, we’ll assess the results and work with your team to fine-tune KEEP’s features to ensure maximum benefit for all patients on Zeposia.
Full-Scale Rollout
Once the pilot is complete, KEEP will be rolled out across all Zeposia patients, helping you deliver improved adherence and engagement at scale.
